XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. Jeffrey Sturchio, Vice President of Merck & Co, talks about the development of protease inhibitors in 1996 and the relationship between the activists and the drug industry.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Conference in Mexico City. American HIV/AIDS pioneer Dr Anthony Fauci from the National Institute of Allergy and Infectious Diseases (NIAID) talks about the disappointments of the latest HIV vaccine trials, and the leadership of Peter Piot.

XVII International AIDS Confrerence in Mexico City. The UNAIDS Executive Director, Peter Piot, is leading the seminar "Taking the Long-Term View AIDS 2031". He talks about the future leadership and international collaboration in HIV and AIDS research.

XVII International AIDS Conference in Mexico City. Interview with Seth Berkley from the International AIDS Vaccine Initiative (IAVI). He talks about the recent media coverage of the failed HIV vaccine study and emphasizes on the positive outcomes of the research process.

XVII International AIDS Conference in Mexico City. Ending of a panel session on the vaccine trials of the International AIDS Vaccine Initiative (IAVI). Seth Berkley, Alan Bernstein and Omu Anzala respond to questions from the audience.

XVII International AIDS Conference in Mexico City. Dr Daria Hazuda from MSD, who has been involved in antiretroviral drug development during the past 20 years, holds a presentation. She is also interviewed about leadership and the progress of ARV and vaccine development.